ArticleERJ open research2025
Association between asthma control and health-related quality of life in severe asthma: a cross-sectional study from KoSAR.
Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Impact of Health Insurance Type on Access to Biologics and Systemic Corticosteroid Exposure in Patients With Severe Asthma: A Real-World Study From the Korean Severe Asthma Registry (KoSAR).Allergy, asthma & immunology research · 2026Article
- Psychological predictors of functioning in patients with asthma.Frontiers in public health · 2026Article
- Expanding Horizons in Severe Asthma: Anti-IgE Biosimilars and the Redefinition of Patient Selection.Allergy, asthma & immunology research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Severe asthma (SA) imposes a significant burden on patients' health-related quality of life (HRQoL). This study aimed to quantify HRQoL burden and identify clinical determinants associated with HRQoL impairment in patients with SA. Methods: Cross-sectional data were collected from 701 patients (592 with SA, 109 with non-severe asthma (NSA)) in the Korean Severe Asthma Registry (KoSAR). HRQoL was measured using the EuroQoL 5-dimension 5-level (EQ-5D-5L) and Severe Asthma Questionnaire (SAQ). Asthma control status was assessed with the Asthma Control Test (ACT) scores. Multivariable and ordinal logistic regression analyses were conducted to identify factors associated with HRQoL. Results: Patients with SA had lower EQ-5D-5L scores than those with NSA (SA: 0.83 Conclusion: Uncontrolled asthma, particularly its impact on daily functioning, was associated with HRQoL impairment in patients with SA. Enhancing asthma control may significantly reduce the disease burden and improve HRQoL in SA.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.